Cytokinetics | CYTK - Cost Of Sales


Cytokinetics reported $5.59M in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Acadia Pharmaceuticals USD 28.32M 3.52M Jun/2026
Amgen USD 1.87B 271M Jun/2026
Bayer EUR 5.23B 731M Mar/2026
Biogen USD 945.1M 147.6M Jun/2026
Bristol-Myers Squibb USD 7.89B 4.03B Jun/2026
Cytokinetics USD 5.59M 5.43M Jun/2026
Eisai JPY 51.09B 926M Jun/2026
Eli Lilly USD 3.27B 309M Jun/2026
Exelixis USD 19.95M 6.53M Mar/2026
Geron USD 1.69M 386K Mar/2026
Halozyme Therapeutics USD 108.68M 67K Jun/2026
Ionis Pharmaceuticals USD 2.74M 261K Jun/2026
Ligand Pharmaceuticals USD 11.31M 59K Jun/2026
Merck USD 3.14B 200M Jun/2026
Novartis USD 3.71B 251M Jun/2026
Pfizer USD 4.09B 498M Jun/2026
Regeneron Pharmaceuticals USD 576.5M 92.9M Jun/2026
Roche Holding CHF 7.85B 630M Jun/2026
Sanofi EUR 3.02B 656M Jun/2026